Pacesetter, Inc.

Siemens-pacesetter, Inc.

Incon-trol Corp.

Diane M Muff

John R Helland

Phong D Doan

Virote Indravudh

Conor Flannery

An implantable cardiac electrotherapy lead is disclosed herein. In one embodiment, the lead includes a tubular body having a distal end with a first soft resilient member. The member extends or is extendable from the distal end radially outward relative to a longitudinal axis of the tubular body.

Reduced perforation distal tip for an implantable cardiac electrotherapy lead

A lead for implantation in a human body exhibits improved combined biodegradation, blood surface compatibility, wear and flexibility characteristics. The lead includes at least one electrode and at least one connector connecting the electrode to a connector at the proximal end of the lead. An outer insulation surrounds the at least one conductor, and includes a first insulation formed of silicone encircling the at least one conductor, and a second insulation formed from polyurethane encircling the silicone rubber insulation.

Cardiac lead with composite insulating structure

A movable self-locking suture sleeve which can be securely positioned on the lead body of a pacing lead. The self-locking suture sleeve includes first and second cooperative rigid elements interconnected by a flexible tubing element. The tubing element is constructed from a woven mesh designed to constrict when stretched. A resilient element or spring is interposed between the first and second cooperative rigid elements, tending to force the cooperative rigid elements axially apart. Once the suture sleeve is moved into position, a self-locking feature allows the suture sleeve to secure itself to the lead body.

Implantable lead having self-locking suture sleeve

A pacing lead having a porous electrode of platinum-iridium with recessed areas or grooves formed into the surface. The grooves allow for acute electrode stabilization as a result of clot formation and endocardial tissue capture during insertion and immediate immobilization upon implant. At least one layer of a porous coating of 20-200 micron diameter spherical particles are deposited on the surface of the base electrode to obtain a porous macrostructure for promoting chronic tissue ingrowth. Additionally, a microstructure surface coating is applied to increase the active surface area and enhance electrical efficiency by lowering electrochemical polarization and increasing electrical capacitance.

Growing community of inventors

Granada Hills, CA, United States of America

Diane M Muff